Endocrinology
Partner With Us
Advertisement
Conexiant chevron_right Endocrinology chevron_right Surgery Versus GLP1 LongTerm Diabetes Outcomes
From the Journals

Surgery Versus GLP-1: Long-Term Diabetes Outcomes

Metabolic surgery associated with lower mortality and retinopathy risk versus glucagon-like peptide-1 therapy in diabetes and obesity.

Conexiant
article Full Article subject Summary summarize Notecard
  1. Metabolic surgery reduces death rates by one-third compared to GLP-1 RAs.
  2. The study analyzed 3,932 adults from 2010-2017.
  3. Primary endpoint: all-cause mortality.
  4. Surgery led to a 9% death rate vs. 12% with medication.
  5. Weight loss was greater: 21% post-surgery vs. 7% with GLP-1 RAs.

Source: Nature Medicine

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.